カテゴリ： 世界, 医療/バイオ, Market Monitor Global

慢性腎臓病治療薬のグローバル市場展望 2023年-2029年：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他

■ 英語タイトル：Chronic Kidney Disease Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8417）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8417
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[慢性腎臓病治療薬のグローバル市場展望 2023年-2029年：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の慢性腎臓病治療薬市場規模と予測を収録しています。・世界の慢性腎臓病治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の慢性腎臓病治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の慢性腎臓病治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ACE阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

慢性腎臓病治療薬のグローバル主要企業は、Keryx Biopharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 AbbVie、 GlaxoSmithKline、 Sanofi、 F. Hoffmann-La Roche Ltd、 Pfizer、 AstraZeneca、 Amgen、 Teva Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、慢性腎臓病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の慢性腎臓病治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の慢性腎臓病治療薬市場：タイプ別市場シェア、2022年
・ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他

世界の慢性腎臓病治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の慢性腎臓病治療薬市場：用途別市場シェア、2022年
・病院、専門医院

世界の慢性腎臓病治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の慢性腎臓病治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における慢性腎臓病治療薬のグローバル売上、2018年-2023年
・主要企業における慢性腎臓病治療薬のグローバル売上シェア、2022年
・主要企業における慢性腎臓病治療薬のグローバル販売量、2018年-2023年
・主要企業における慢性腎臓病治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Keryx Biopharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 AbbVie、 GlaxoSmithKline、 Sanofi、 F. Hoffmann-La Roche Ltd、 Pfizer、 AstraZeneca、 Amgen、 Teva Pharmaceutical Industries

*************************************************************

・調査・分析レポートの概要
慢性腎臓病治療薬市場の定義
市場セグメント
世界の慢性腎臓病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の慢性腎臓病治療薬市場規模
世界の慢性腎臓病治療薬市場規模：2022年 VS 2029年
世界の慢性腎臓病治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの慢性腎臓病治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の慢性腎臓病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他
慢性腎臓病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門医院
慢性腎臓病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別慢性腎臓病治療薬市場規模 2022年と2029年
地域別慢性腎臓病治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Keryx Biopharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 AbbVie、 GlaxoSmithKline、 Sanofi、 F. Hoffmann-La Roche Ltd、 Pfizer、 AstraZeneca、 Amgen、 Teva Pharmaceutical Industries
...

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease Drugs. This report contains market size and forecasts of Chronic Kidney Disease Drugs in global, including the following market information:
Global Chronic Kidney Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Chronic Kidney Disease Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Chronic Kidney Disease Drugs companies in 2022 (%)
The global Chronic Kidney Disease Drugs market was valued at US$ 11200 million in 2022 and is projected to reach US$ 12620 million by 2029, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ACE Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Kidney Disease Drugs include Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Kidney Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Kidney Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, by Type, 2022 (%)
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Global Chronic Kidney Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chronic Kidney Disease Drugs revenues share in global market, 2022 (%)
Key companies Chronic Kidney Disease Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Chronic Kidney Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Kidney Disease Drugs, market overview.
Chapter 2: Global Chronic Kidney Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Kidney Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease Drugs Overall Market Size
2.1 Global Chronic Kidney Disease Drugs Market Size: 2022 VS 2029
2.2 Global Chronic Kidney Disease Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chronic Kidney Disease Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Chronic Kidney Disease Drugs Players in Global Market
3.2 Top Global Chronic Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease Drugs Revenue by Companies
3.4 Global Chronic Kidney Disease Drugs Sales by Companies
3.5 Global Chronic Kidney Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Kidney Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Chronic Kidney Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type – Global Chronic Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type – Global Chronic Kidney Disease Drugs Revenue, 2018-2023
4.2.2 By Type – Global Chronic Kidney Disease Drugs Revenue, 2024-2029
4.2.3 By Type – Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Chronic Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type – Global Chronic Kidney Disease Drugs Sales, 2018-2023
4.3.2 By Type – Global Chronic Kidney Disease Drugs Sales, 2024-2029
4.3.3 By Type – Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chronic Kidney Disease Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application – Global Chronic Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application – Global Chronic Kidney Disease Drugs Revenue, 2018-2023
5.2.2 By Application – Global Chronic Kidney Disease Drugs Revenue, 2024-2029
5.2.3 By Application – Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Chronic Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application – Global Chronic Kidney Disease Drugs Sales, 2018-2023
5.3.2 By Application – Global Chronic Kidney Disease Drugs Sales, 2024-2029
5.3.3 By Application – Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Chronic Kidney Disease Drugs Market Size, 2022 & 2029
6.2 By Region – Global Chronic Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region – Global Chronic Kidney Disease Drugs Revenue, 2018-2023
6.2.2 By Region – Global Chronic Kidney Disease Drugs Revenue, 2024-2029
6.2.3 By Region – Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Chronic Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region – Global Chronic Kidney Disease Drugs Sales, 2018-2023
6.3.2 By Region – Global Chronic Kidney Disease Drugs Sales, 2024-2029
6.3.3 By Region – Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Chronic Kidney Disease Drugs Revenue, 2018-2029
6.4.2 By Country – North America Chronic Kidney Disease Drugs Sales, 2018-2029
6.4.3 US Chronic Kidney Disease Drugs Market Size, 2018-2029
6.4.4 Canada Chronic Kidney Disease Drugs Market Size, 2018-2029
6.4.5 Mexico Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Chronic Kidney Disease Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Chronic Kidney Disease Drugs Sales, 2018-2029
6.5.3 Germany Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.4 France Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.5 U.K. Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.6 Italy Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.7 Russia Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Chronic Kidney Disease Drugs Market Size, 2018-2029
6.5.9 Benelux Chronic Kidney Disease Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Chronic Kidney Disease Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Chronic Kidney Disease Drugs Sales, 2018-2029
6.6.3 China Chronic Kidney Disease Drugs Market Size, 2018-2029
6.6.4 Japan Chronic Kidney Disease Drugs Market Size, 2018-2029
6.6.5 South Korea Chronic Kidney Disease Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Chronic Kidney Disease Drugs Market Size, 2018-2029
6.6.7 India Chronic Kidney Disease Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Chronic Kidney Disease Drugs Revenue, 2018-2029
6.7.2 By Country – South America Chronic Kidney Disease Drugs Sales, 2018-2029
6.7.3 Brazil Chronic Kidney Disease Drugs Market Size, 2018-2029
6.7.4 Argentina Chronic Kidney Disease Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Chronic Kidney Disease Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Chronic Kidney Disease Drugs Sales, 2018-2029
6.8.3 Turkey Chronic Kidney Disease Drugs Market Size, 2018-2029
6.8.4 Israel Chronic Kidney Disease Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Chronic Kidney Disease Drugs Market Size, 2018-2029
6.8.6 UAE Chronic Kidney Disease Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Keryx Biopharmaceuticals, Inc
7.1.1 Keryx Biopharmaceuticals, Inc Company Summary
7.1.2 Keryx Biopharmaceuticals, Inc Business Overview
7.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Major Product Offerings
7.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Keryx Biopharmaceuticals, Inc Key News & Latest Developments
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Chronic Kidney Disease Drugs Major Product Offerings
7.3.4 AbbVie Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Chronic Kidney Disease Drugs Major Product Offerings
7.5.4 Sanofi Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Kidney Disease Drugs Major Product Offerings
7.7.4 Pfizer Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Chronic Kidney Disease Drugs Major Product Offerings
7.8.4 AstraZeneca Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Chronic Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Chronic Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Chronic Kidney Disease Drugs Production Capacity, 2018-2029
8.2 Chronic Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Kidney Disease Drugs Supply Chain Analysis
10.1 Chronic Kidney Disease Drugs Industry Value Chain
10.2 Chronic Kidney Disease Drugs Upstream Market
10.3 Chronic Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他
  • 末梢血管用拡張薬のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、α-アドレナリン遮断薬、カリウムチャネル活性化薬、その他
  • 片頭痛予防治療のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他
  • 慢性腎臓病用治療薬のグローバル市場展望 2023年-2029年：カルシウム模倣薬、ビタミンD、ステロール、カリウム結合剤、カルシウム系リン酸塩結合剤
  • 世界の腎臓病治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8417 )"慢性腎臓病治療薬のグローバル市場展望 2023年-2029年：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他" (英文：Chronic Kidney Disease Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。